A biological classification of Huntington's disease: the Integrated Staging System
SJ Tabrizi, S Schobel, EC Gantman… - The Lancet …, 2022 - thelancet.com
The current research paradigm for Huntington's disease is based on participants with overt
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
A biological classification of Huntington's disease: the Integrated Staging System
SJ Tabrizi, S Schobel, EC Gantman… - Lancet …, 2022 - discovery.ucl.ac.uk
The current research paradigm for Huntington's disease is based on participants with overt
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
A biological classification of Huntington's disease: the Integrated Staging System
SJ Tabrizi, S Schobel, EC Gantman, A Mansbach… - Lancet …, 2022 - iro.uiowa.edu
The current research paradigm for Huntington's disease is based on participants with overt
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
A biological classification of Huntington's disease: the Integrated Staging System
SJ Tabrizi, S Schobel, EC Gantman… - The Lancet …, 2022 - pubmed.ncbi.nlm.nih.gov
The current research paradigm for Huntington's disease is based on participants with overt
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
A biological classification of Huntington's disease: the Integrated Staging System
Huntington's Disease Regulatory … - The Lancet …, 2022 - pure.johnshopkins.edu
The current research paradigm for Huntington's disease is based on participants with overt
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
A biological classification of Huntington's disease: the Integrated Staging System.
SJ Tabrizi, S Schobel, EC Gantman… - The Lancet …, 2022 - europepmc.org
The current research paradigm for Huntington's disease is based on participants with overt
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
A biological classification of Huntington's disease: the Integrated Staging System
SJ Tabrizi, S Schobel, EC Gantman, A Mansbach… - The Lancet …, 2022 - Elsevier
The current research paradigm for Huntington's disease is based on participants with overt
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …
clinical phenotypes and does not address its pathophysiology nor the biomarker changes …